7-nitroindazole has been researched along with riluzole in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Boireau, A; Bordier, F; Dubedat, P; Imperato, A; Moussaoui, S | 1 |
| Boczkowski, J; Desmonts, JM; Keita, H; Lang-Lazdunski, L; Lanone, S; Mantz, J; Rouellé, D; Samb, A | 1 |
| Dagci, T; Peker, G; Taskiran, D; Yilmaz, O | 1 |
| Artinian, L; Rehder, V; Yang, H; Zhong, L | 1 |
6 other study(ies) available for 7-nitroindazole and riluzole
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP(+) accumulation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Indazoles; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Parkinson Disease, Secondary; Riluzole | 2000 |
Anesthetic concentrations of riluzole inhibit neuronal nitric oxide synthase activity, but not expression, in the rat hippocampus.
Topics: Actins; Anesthetics; Animals; Enzyme Inhibitors; Hippocampus; Indazoles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Riluzole | 2000 |
Neuroprotective agents: is effective on toxicity in glial cells?
Topics: Animals; Anticonvulsants; Cells, Cultured; Drug Interactions; Glutamic Acid; Indazoles; L-Lactate Dehydrogenase; Melatonin; Neuroglia; Neuroprotective Agents; Nitrates; Rats; Rats, Sprague-Dawley; Riluzole | 2007 |
Nitric oxide as intracellular modulator: internal production of NO increases neuronal excitability via modulation of several ionic conductances.
Topics: Action Potentials; Animals; Apamin; Calcium Channels; Citrulline; Cyclic GMP-Dependent Protein Kinases; Enzyme Inhibitors; Guanylate Cyclase; Indazoles; Neurons; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Potassium Channel Blockers; Receptors, Cytoplasmic and Nuclear; Riluzole; Small-Conductance Calcium-Activated Potassium Channels; Snails; Sodium Channel Blockers; Sodium Channels; Soluble Guanylyl Cyclase; Thiourea | 2012 |